| Identification | Back Directory | [Name]
(2S,5S)-5-[4-Amino-5-[4-(2,3-difluorophenoxy)phenyl]imidazo[5,1-f][1,2,4]triazin-7-yl]tetrahydro-2H-pyran-2-methanol | [CAS]
2662512-15-2 | [Synonyms]
BTK-IN-30
(2S,5S)-5-[4-Amino-5-[4-(2,3-difluorophenoxy)phenyl]imidazo[5,1-f][1,2,4]triazin-7-yl]tetrahydro-2H-pyran-2-methanol | [Molecular Formula]
C23H21F2N5O3 | [MOL File]
2662512-15-2.mol | [Molecular Weight]
453.44 |
| Hazard Information | Back Directory | [Uses]
Birelentinib (compound cpd15) is an inhibitor of Bruton's tyrosine kinase (BTK) and mutant BTK with IC50 values of 6.72 and 6.11 nM, respectively[1]. | [References]
[1] Quan Zhou, et al. Btk inhibitors. WO2021136219A1. 2020. |
|
|